RAC has been on my watchlist for a while - I've never quite pulled the trigger.
The thing that is bugging me: with such a massive clinical trial history, would a highly effective drug ever be lost for 25 years?
One of the articles which comes up on page 1 when Googling 'bistantrene' is this - https://www.epmmagazine.com/pharma-manufacturing-news/why-this-cancer-drug-was-lost-for-25-years/
These are some of the quotes published in the article:
“There’s so much clinical history on this drug, it’s been in 1,800 patients and 46 phase II trials in various cancers,” Race Oncology CEO Peter Molloy told European Pharmaceutical Manufacturer.
“Frankly, when I worked in big pharma, I would have deprioritised [Bisantrene] as well because from big pharma’s perspective it was never going to be a billion-dollar drug,” Molloy states.
As an aside, I'm not surprised Molloy is no longer around given statements like the above!
Comments from the RAC community would be appreciated.
- Forums
- General
- General Comments / Chat
RAC has been on my watchlist for a while - I've never quite...
-
- There are more pages in this discussion • 7,337 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.83 |
Change
0.020(1.11%) |
Mkt cap ! $310.7M |
Open | High | Low | Value | Volume |
$1.81 | $1.83 | $1.79 | $142.0K | 78.77K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $1.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.83 | 641 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 1.810 |
3 | 7009 | 1.790 |
1 | 450 | 1.780 |
2 | 16392 | 1.770 |
2 | 1018 | 1.765 |
Price($) | Vol. | No. |
---|---|---|
1.830 | 558 | 1 |
1.840 | 4000 | 2 |
1.845 | 2746 | 1 |
1.860 | 1000 | 1 |
1.870 | 1200 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online